Page 19 - Clinical Programs News Today

Dr. Weingardt, a clinical psychologist and previously a Senior Clinical Director at Pear Therapeutics will guide MINDCUREs digital therapeutics technology platform, iSTRYM, through near-term... | August 11, 2021

/PRNewswire/ - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE" or the "Company"), a leader in advanced proprietary technology and...

Genetic Health Information Network Summit Will Address Data and Digital Infrastructure for Precision Medicine News provided by Share this article Share this article NASHVILLE, Tenn., June 10, 2021 /PRNewswire/ -- Concert Genetics, in collaboration with leaders from across genetics and healthcare, today announced the 4th Genetic Health Information Network Summit will take place October 25-27, 2021, in Nashville, Tenn. This event assembles leaders at the intersection of genetics, technology, and ...

LA JOLLA, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Equillium, Inc. (Nasdaq: EQ), a clinical-stage biotechnology company developing itolizumab to treat severe autoimmune and inflammatory disorders, announced today that it will present at the JMP Securities Life Sciences Conference, a virtual investor event, taking place June 16 and 17, 2021. Bruce Steel, Equillium’s chief executive officer, will provide a high-level overview of itolizumab’s mechanism of action and review each of th...

Three TriTAC clinical programs (HPN424, HPN536 and HPN328) have shown tumor size reductions or stable disease, and meaningful treatment durationAll four clinical programs demonstrate half-life extension, target engagement and T cell activationCytokine release syndrome observed and manageable, with low incidence of severe CRSManagement to host webcast and conference call to review the interim data presented at ASCO and provide a pipeline update today at 4 p.m. ET /1 p.m. PT SOUTH SAN FRANCISCO, C

119 Abstracts and Presentations Featuring Sarah Cannon's Clinical Research and Care Insights Today, Sarah Cannon announced it will present its latest cancer research insights at the American Society

SAN DIEGO, May 17, 2021 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of industry veteran Salim Yazji, M.D., as Chief Medical Officer. “Salim brings a wealth of relevant experience to Oncternal during this exciting time as we begin to advance our pipeline toward the registrational phase,” said James Breitmeyer, M.D., Ph.D., Oncternal&...

Article content TORONTO — NexJ Health Inc. (NexJ Health), a provider of advanced virtual care solutions for chronic disease prevention and management, is pleased to announce the encouraging results of a Randomized Controlled Trial (RCT) using NexJ Connected Wellness. The study evaluated online mindfulness-based Cognitive Behavioural Therapy (CBT-M) for young adults with major depressive disorder (MDD). The intervention demonstrated large improvements, especially in severely depressed partic...

The faculty and staff at the Texas Tech School of Veterinary Medicine now know who will be in their inaugural class. There was a specific mission in mind when deciding who the admissions committee would offer the opportunity to study at the Tech School of Veterinary Medicine. Dr. John Dascanio is a theriogenology professor and is the senior associate dean for Academic and Student Services at the Tech School of Veterinary Medicine. Dascanio discussed the mission that was kept in mind for what th...

Published: Apr 19, 2021   BEVERLY HILLS, Calif., April 19, 2021 /PRNewswire/ -- GT Biopharma, Inc. (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative therapeutics based on the Companys proprietary natural killer (NK) cell engager (TriKE™) protein biologic technology platform, reported financial results for the fourth quarter and year ended December 31, 2020. "2020 was a year of robust clinical progress and milestone achievements for GT Biopharma, w...